| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MASIMO CORP | EVP, Ops & Clinical Research | Common Stock | 40,909 | $5,649,123 | $138.09 | 28 Jan 2026 | Direct |
| MASIMO CORP | EVP, Ops & Clinical Research | Non-Qualified Stock Option (Right to Buy) | 0 | 28 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MASI | MASIMO CORP | 28 Jan 2026 | 5 | -$1,420,370 | 4 | EVP, Ops & Clinical Research | 30 Jan 2026, 20:13 |